Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review

Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review

Background: Dolutegravir (DTG) is a cornerstone of global antiretroviral (ARV) therapy (ART) due to its high efficacy and favorable tolerability. However, limited data exist regarding the risk of emergent integrase strand transfer inhibitor (INSTI) drug-resistance mutations (DRMs) in individuals rec...

Full description

Bibliographic Details
Main Authors: Carolyn Chu, Kaiming Tao, Vinie Kouamou, Ava Avalos, Jake Scott, Philip M. Grant, Soo-Yon Rhee, Suzanne M. McCluskey, Michael R. Jordan, Rebecca L. Morgan, Robert W. Shafer
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Viruses
Subjects:
HIV
epidemiology
systematic review
treatment
Online Access:https://www.mdpi.com/1999-4915/16/3/399

Internet

https://www.mdpi.com/1999-4915/16/3/399

Similar Items